Celebrex - Celecoxib capsules - Pfizer - COX-2 inhibitor approved for ankylosing spondylitis

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2005年 / 40卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：296 / 296
页数：1
相关论文
共 50 条
  • [31] Antifibrotic potential of a selective COX-2 inhibitor (celecoxib) on liver fibrosis in rats
    Ftahy M.M.
    Latif N.S.A.
    Alalkamy E.F.
    El-Batrawi F.A.
    Galal A.H.
    Khatab H.M.
    Comparative Clinical Pathology, 2013, 22 (3) : 425 - 430
  • [32] Efficacy and safety of celecoxib, a specific COX-2 inhibitor in patients with rheumatoid arthritis
    Geis, GS
    Hubbard, RC
    Callison, DA
    Yu, S
    Zhao, W
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S70 - S70
  • [33] Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH
    Wang, Jiping
    Cho, Nancy L.
    Zauber, Ann G.
    Hsu, Meier
    Dawson, Dawn
    Srivastava, Amitabh
    Mitchell-Richards, Kisha A.
    Markowitz, Sanford D.
    Bertagnolli, Monica M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 728 - 736
  • [34] COX-2 inhibitor
    Gotzsche, P. C.
    Bjarnasoni, N. H.
    RHEUMATOLOGY, 2007, 46 (10) : 1623 - 1624
  • [35] Etoricoxib, a COX-2 selective inhibitor, in ankylosing spondylitis (AS) patients with poor response to nonsteroidal anti-inflammatory drugs (NSAIDs)
    Emery, R
    Baraf, HS
    Schiff, M
    Dougados, M
    Van der Heijde, D
    Ramos-Remus, C
    Estevez, EC
    Calin, A
    Kvien, TK
    Melian, A
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 99 - 99
  • [36] Design and synthesis of selective COX-2 inhibitors: Identification of Celebrex.
    Miyashiro, JM
    Bertenshaw, SR
    Carter, JS
    Collins, PW
    Docter, S
    Graneto, MJ
    Lee, LF
    Malecha, JW
    Penning, TD
    Rogers, RS
    Rogier, DJ
    Talley, JJ
    Yu, SS
    Anderson, GD
    Burton, EG
    Cogburn, JN
    Gregory, SA
    Isakson, PC
    Koboldt, CM
    Masferrer, JL
    Perkins, WE
    Seibert, K
    Veenhuizen, AW
    Zhang, YY
    Zweifel, BS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U110 - U111
  • [37] Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines
    Bocca, Claudia
    Bozzo, Francesca
    Bassignana, Andrea
    Miglietta, Antonella
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2011, 350 (1-2) : 59 - 70
  • [38] The effects of celecoxib, a COX-2 selective inhibitor, on acute inflammation induced in irradiated rats
    Khayyal M.T.
    El-Ghazaly M.A.
    El-Hazek R.M.
    Nada A.S.
    Inflammopharmacology, 2009, 17 (5) : 255 - 266
  • [39] Safety and efficacy of celecoxib, a specific COX-2 inhibitor, in patients with rheumatoid arthritis.
    Geis, GS
    Hubbard, R
    Callison, D
    Yu, S
    Zhao, W
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S364 - S364
  • [40] Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib
    Cahill, Ronan A.
    ANNALS OF SURGERY, 2006, 244 (02) : 327 - 328
12345